Qualitative analysis of experiences, burdens, and needs among patients with hypertrophic cardiomyopathy in Japan
Yuichiro Maekawa(Hamamatsu University School of Medicine), Hiroaki Kitaoka(University of Kochi), Kanako Shimoura(CombiMatrix), Ryohei Takeda(CombiMatrix), Shintaro Suo(CombiMatrix), Makio Torigoe(Bristol-Myers Squibb (Germany)), Yuika Ikeda(Bristol-Myers Squibb (Germany))
Cited by 0
Related Papers
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
|New England Journal of Medicine|2025|51
Effect of Dehydration on the Formation of Levofloxacin Pseudopolymorphs.
|Chemical and Pharmaceutical Bulletin|1995|47
Photochemical Behavior of Sitafloxacin, Fluoroquinolone Antibiotic, in an Aqueous Solution.
|Chemical and Pharmaceutical Bulletin|2002|34
Phase 3 Open-Label Study Evaluating the Efficacy and Safety of Mavacamten in Japanese Adults With Obstructive Hypertrophic Cardiomyopathy ― The HORIZON-HCM Study ―
|Circulation Journal|2024|23
The Mechanism of Reaction of Ebselen with Superoxide in Aprotic Solvents as Examined by Cyclic Voltammetry and ESR.
|Chemical and Pharmaceutical Bulletin|2001|22